Recharacterization of the nonlesional dry skin in atopic dermatitis through disrupted barrier function

Exogenous Dermatology

Volumn 3, Issue 6, 2006, Pages 282-292

  Matsuki, Hayato ^a   Kiyokane, Kimihiro ^a   Matsuki, Takahiro ^b   Sato, Sayuri ^b   Imokawa, Genji ^c,d  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b FUKUOKA SANNO HOSPITAL   (Japan)

^c Skin Science Research Institute   (Japan)

^d Skin Science Research Institute   (Japan)

Author keywords

Atopic dermatitis; Capacitance; Disrupted barrier function; Transepidermal water loss

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DISEASE SEVERITY; DRY SKIN; ELECTRIC CAPACITANCE; EVALUATION; FEMALE; FOREARM; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PARAMETER; PERMEABILITY BARRIER; PRIORITY JOURNAL; PRURITUS; SKIN BARRIER DYSFUNCTION; SKIN DISEASE; SKIN SCALING; SKIN WATER LOSS; WATER CONTENT;

EID: 33745283677     PISSN: 14244616     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091909     Document Type: Article

References (39)

1. Strid J, Strobel S: Skin barrier dysfunction and systemic sensitization to allergens through the skin. Curr Drug Targets Inflamm Allergy 2005;4:531-541.
2. Dirschka T, Szkusja C, Jackowski J, Tronnier H: Impaired skin barrier and atopic diathesis in perioral dermatitis. J Dtsch Dermatol Ges 2003;1:199-203.
3. Choi MJ, Maibach HI: Role of ceramides in barrier function of healthy and diseased skin. Am J Clin Dermatol 2005;6:215-223.
4. Hata M, Tokura Y, Takigawa M, Sato M, Shioya Y, Fujikura Y, Imokawa G: Assessment of epidermal barrier function by photoacoustic spectrometry in relation to its importance in the pathogenesis of atopic dermatitis. Lab Invest 2002;82:1451-1461.
5. Imokawa G: Ceramides as natural moisturizing factors and their efficacy in dry skin; in Leyden JJ, Rawlings AV (eds): Skin Moisturization. New York, Marcel Dekker, 2002, pp 267-302.
6. Watanabe M, Tagami H, Horii I, Takahashi M, Kligman AM: Functional analysis of the superficial stratum corneum in atopic xerosis. Arch Dermatol 1991;127:1689-1692.
7. Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A: Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol 1991;96:523-526.
8. Imokawa G: Skin moisturizers: Development and clinical use of ceramides; in Loden M (ed): Dry Skin and Moisturizers. Boca Raton, CRC Press, 1999, pp 269-299.
9. Umeda Y, Mizutani H, Imokawa G, Shimizu M: Topical ceramide corrected epidermal cell hyperproliferation and stratum corneum dysmaturation in atopic eczema. N Trends Allergy 1997;4:237-239.
10. Murata Y, Ogata J, Higaki Y, Kawashima M, Yada Y, Tsuchiya T, Kawaminami S, Imokawa G: Abnormal expression of sphingomyelin acylase in atopic dermatitis: an etiologic factor for ceramide deficiency? J Invest Dermatol 1996;106:1242-1249.
11. Hara J, Higuchi K, Okamoto R, Kawashima M, Imokawa G: High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis. J Invest Dermatol 2000;115:406-413.
12. Higuchi K, Hara J, Okamoto R, Kawashima M, Imokawa G: The skin of atopic dermatitis patients contains a novel enzyme, glucosylceramide sphingomyelin deacylase, which cleaves the N-acyl linkage of sphingomyelin and glucosylceramide. Biochem J 2000;350:747-756.
13. Ishibashi M, Arikawa J, Okamoto R, Kawashima M, Takagi Y, Oguchi K, Imokawa G: The abnormal expression of the novel epidermal enzyme, glucosylceramide deacylase and the accumulation of its enzymatic reaction product, glucosylsphingosine in the skin of patients with atopic dermatitis. Lab Invest 2003;88:397-408.
14. Okamoto R, Arikawa J, Ishibashi M, Kawashima M, Takagi Y, Imokawa G: Sphingosylphosphorylcholine levels are significantly increased in the stratum corneum of patients with atopic dermatitis: physiological and functional relevance of sphingomyelin deacylase to the ceramide deficiency. J Lipid Res 2003;44:93-102.
15. Imokawa G: Lipid abnormalities in atopic dermatitis. J Am Acad Dermatol 2001;45:S29-S32.
16. Hanifin JM, Rajka G: Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1989;92:44-47.
17. Rajika G, Langeland T: Grading of the severity of atopic dermatitis. Acta Dermatovenereol Suppl (Stockh) 1989;144:13-14.
18. Berardesca E: EEMCO guidance for the assessment of stratum corneum hydration: electrical methods. Skin Res Technol 1997;3:126-132.
19. Pinnagoda J, Tupker RA, Agner T, et al: Guidelines for transepidermal water loss (TEWL) measurement. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis 1990;22:164-178.
20. De Paepe K, Houben E, Adam R, Wisemann F, Rogiers V: Validation of the VapoMeter, a closed unventilated chamber system to assess transepidermal water loss vs. the open chamber Tewameter. Skin Res Technol 2005;11:61-69.
21. Ogawa H, Yoshiike T: A speculative view of atopic dermatitis: barrier dysfunction in pathogenesis. J Dermatol Sci 1993;5:197-204.
22. Imokawa G, Hattori M: A possible function of structural lipid in the water-holding properties of the stratum corneum. J Invest Dermatol 1985;84:282-284.
23. Imokawa G, Akasaki S, Minematsu Y, Kawai M: Importance of intercellular lipids in water-retention properties of the stratum corneum: induction and recovery study of surfactant dry skin. Arch Dermatol Res 1989;281:45-51.
24. Imokawa G, Kuno H, Kawai M: Stratum corneum lipids serve as a bound-water modulator. J Invest Dermatol 1991;96:845-851.
25. Imokawa G, Akasaki S, Minematsu Y, Kuno O, Zama M, Kawai M, Hattori M, Yoshizuka N, Kawamata A, Yano Y, Takaishi N: Function of lipids on human skin. J Disp Sci Tech 1989;10:617-641.
26. Surgarman JL, Fluhr JW, Fowler AJ, Bruckner T, Diepgen TL, Williams ML: The objective severity assessment of atopic dermatitis score. An objective measure using permeability barrier function and stratum corneum hydration with computer-assisted estimates for extent of disease. Arch Dermatol 2003;139:1417-1422.
27. Sugarman JL, Fluhr JW, Fowler AJ, Bruckner T, Diepgen TL, Williams ML: The objective severity assessment of atopic dermatitis score: an objective measure using permeability barrier function and stratum corneum hydration with computer-assisted estimates for extent of disease. Arch Dermatol 2003;139:1490-1492.
28. Angelova-Fischer I, Bauer A, Hipler UC, Petrov I, Kazandjieva J, Bruckner T, Diepgen T, Tsankov N, Williams M, Fischer TW, Elsner P, Fluhr JW: The objective severity assessment of atopic dermatitis (OSAAD): validity, reliability and sensitivity in adult patients with atopic dermatitis. Br J Dermatol 2005;154:767-773.
29. Imokawa G: Water and the stratum corneum; in Elsner P, Berardesca E, Maibach HI (eds): Bioengineering of Skill. In vitro and in vivo Models. Boca Raton, CRC Press, chapter 3, vol 1, 1993, pp 23-47.
30. Wakita H, Sakamoto T, Tokura Y, Takigawa M: E-selectin and vascular cell adhesion molecule-1 as critical adhesion molecules for infiltration of T lymphocytes and eosinophils in atopic dermatitis. J Cutan Pathol 1994;21:33-39.
31. Tupker RA, Pinnagoda J, Coenraads PJ, Nater JP: Susceptibility to irritants: role of barrier function, skin dryness and history of atopic dermatitis. Br J Dermatol 1990;123:199-205.
32. Tanaka M, Aiba S, Matsumura N, Aoyama H, Tabata N, Sekita Y, Tagami H: IgE-mediated hypersensitivity and contact sensitivity to multiple environmental allergens in atopic dermatitis. Arch Dermatol 1994;130:1393-1401.
33. Fitzharris P, Riley G: House dust mites in atopic dermatitis. Int J Dermatol 1999;38:173-175.
34. Deleuran M, Ellingsen AR, Paludan K, Schou C, Thestrup-Pedersen K: Purified Der p1 and p2 patch tests in patients with atopic dermatitis: evidence for both allergenicity and proteolytic irritancy. Acta Derm Venereol 1998;78:241-243.
35. Rothe MJ, Grant-Kels JM: Atopic dermatitis: an update. J Am Acad Dermatol 1996;35:1-13.
36. Tan BB, Weald D, Strickland I, Friedmann PS: Double-blind controlled trial of effect of house-dust-mite allergen avoidance on atopic dermatitis. Lancet 1996;6:15-18.
37. Cooper KD: Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1994;102:128-137.
38. Uehara M: Heterogeneity of serum IgE levels in atopic dermatitis. Acta Derm Venereol 1986;66:404-408.
39. Kondo H, Ichikawa Y, Imokawa G: Percutaneous sensitization with allergens through barrier-disrupted skin elicits a Th2-dominant cytokine response. Eur J Immunol 1998;28:769-779.